default author photo

Camilla V. Myklebust

University of Oslo - KG Jebsen Centre for B Cell Malignancies

Norway

SCHOLARLY PAPERS

1

DOWNLOADS

56

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Preexisting Cross-Reactive T Cells are Boosted and Comprise Significant Immunity in COVID-19 Recovered Patients

Number of pages: 55 Posted: 24 Feb 2021
University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - KG Jebsen Centre for B Cell Malignancies, University of Oslo - Institute of Clinical Medicine, Vestre Viken Hospital Trust, Oslo University Hospital - Department of Immunology, University of Oslo - Department of Immunology and Transfusion Medicine, Oslo University Hospital - Department of Microbiology, Norwegian Institute of Public - Department of Infectious Disease Surveillance and Environmental Health, Norwegian Institute of Public Health - Department of Method Development and Analytics, University of Oslo - Institute of Clinical Medicine and University of Oslo - KG Jebsen Centre for B Cell Malignancies
Downloads 56 (1,000,027)
Citation 1

Abstract:

Loading...